OSE Immunotherapeutics Receives Special Recognition for European Growth, Healthcare Enterprise and Women Entrepreneurship

NEXT STORY
Spring Bank Pharmaceuticals Announces Election of Pamela Klein, M.D., to its Board of Directors
PREV STORY
Generex Biotechnology Provides Fiscal Year Overview
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

The University of Texas Health Science Center at Houston joins Biomerica’s InFoods® Irritable Bowel Syndrome (“IBS”) Diagnostic-Guided Therapy (“DGT”) clinical trial

author_avatar
NASDAQ Market News

Stemline Therapeutics Reports Second Quarter 2016 Financial Results and Highlights Recent Clinical Progress

NEW YORK, Aug. 04, 2016 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) today reported ...

author_avatar
NASDAQ Market News

Y-mAbs Announces Appointment of Gérard Ber to its Board of Directors and Planned Departure of Michael Buschle

NEW YORK, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or ...

author_avatar
NASDAQ Market News